MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1592/phco.22.12.1029.33595

Медицинская библиотека · Pharmacotherapy · 2002

Do butalbital-containing products have a role in the management of migraine?

Wenzel Richard G, Sarvis Carrie A

СтатьяОбзорПеревод в очереди

Аннотация

STUDY

OBJECTIVE

To evaluate the role of butalbital-containing products in the management of migraine.

METHODS

Qualitative systematic search using MEDLINE (January 1966-November 2001), review of the United States Headache Consortium's evidence-based guidelines for migraine treatment, and review of other pertinent literature.

RESULTS

Over 28 million people suffer with migraine, yet this illness is less than optimally diagnosed and managed. Between 14% and 36% of diagnosed migraineurs are prescribed butalbital-containing products, often as initial therapy. However, the only identified controlled trial of these drugs for migraine treatment showed that butalbital-containing products were inferior to butorphanol. The consortium's guidelines specifically discourage administration of butalbital-containing products for migraine. In addition, other published literature highlights the frequent adverse consequences of butalbital-containing products for migraineurs, such as poor migraine control, disability, drug-induced headaches, and withdrawal symptoms.

CONCLUSION

Although butalbital-containing products commonly are prescribed for migraine, no evidence in the literature demonstrates their benefit over other agents or placebo. Drugs with proven migraine efficacy, as listed in the consortium's evidence-based guidelines, should be prescribed instead.

Для цитирования: Wenzel Richard G, Sarvis Carrie A. Do butalbital-containing products have a role in the management of migraine?. Pharmacotherapy. 2002. DOI: 10.1592/phco.22.12.1029.33595.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.